This grant, offered by the Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC), is for investigator-initiated research. Its primary purpose is to rigorously evaluate the effectiveness of policies designed to reduce drug use and prevent overdose. A key focus is understanding how these policies impact existing disparities in medical care and health outcomes, particularly among groups disproportionately affected by overdose or at higher risk due to social determinants of health. The research should also explore policy implementation and its effect on achieving intended outcomes. Proposed projects must assess the impact of a local, state, tribal, federal, or organizational policy on at least two overdose outcomes, such as fatal or nonfatal overdose, or substance use disorders.
Opportunity ID: 347316
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CE-24-012 |
Funding Opportunity Title: | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Aug 30, 2023 |
Last Updated Date: | Sep 29, 2023 |
Original Closing Date for Applications: | Dec 01, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Dec 01, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Dec 31, 2023 |
Estimated Total Program Funding: | $2,100,000 |
Award Ceiling: | $350,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities For profit organizations other than small businesses County governments Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Private institutions of higher education Public and State controlled institutions of higher education State governments Small businesses |
Additional Information on Eligibility: | See Section III. Eligibility Information |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health.The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Joyce Dieterly, MPH
ncipc_erpo@cdc.gov Email:ncipc_erpo@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
The purpose of this modification of the NOFO is to correct language about the total funding amount for the award. All other information remains the same. | Sep 29, 2023 | |
To update the due date on face page and correct template language around Letter of Intent | Aug 30, 2023 | |
Aug 30, 2023 | ||
Apr 04, 2023 |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CE-24-012 |
Funding Opportunity Title: | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Aug 30, 2023 |
Last Updated Date: | Sep 29, 2023 |
Original Closing Date for Applications: | Dec 01, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Current Closing Date for Applications: | Dec 01, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Dec 31, 2023 |
Estimated Total Program Funding: | $2,100,000 |
Award Ceiling: | $350,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities For profit organizations other than small businesses County governments Independent school districts Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Private institutions of higher education Public and State controlled institutions of higher education State governments Small businesses |
Additional Information on Eligibility: | See Section III. Eligibility Information |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health.The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Joyce Dieterly, MPH
ncipc_erpo@cdc.gov Email:ncipc_erpo@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CE-24-012 |
Funding Opportunity Title: | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Aug 30, 2023 |
Last Updated Date: | Sep 21, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Dec 01, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Dec 31, 2023 |
Estimated Total Program Funding: | $2,100,000 |
Award Ceiling: | $350,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Small businesses For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Native American tribal governments (Federally recognized) City or township governments Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | See Section III. Eligibility Information |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health.The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Joyce Dieterly, MPH
ncipc_erpo@cdc.gov Email:ncipc_erpo@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CE-24-012 |
Funding Opportunity Title: | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 30, 2023 |
Last Updated Date: | Aug 30, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Dec 01, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date. |
Archive Date: | Mar 09, 2024 |
Estimated Total Program Funding: | $2,100,000 |
Award Ceiling: | $350,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Small businesses For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Native American tribal governments (Federally recognized) City or township governments Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | See Section III. Eligibility Information |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health.The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Joyce Dieterly, MPH
ncipc_erpo@cdc.gov Email:ncipc_erpo@cdc.gov |
DISPLAYING: Forecast 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CE-24-012 |
Funding Opportunity Title: | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 2 |
Assistance Listings: | 93.136 — Injury Prevention and Control Research and State and Community Based Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Forecast 1 |
Posted Date: | Apr 04, 2023 |
Last Updated Date: | Apr 04, 2023 |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | – |
Archive Date: | Mar 09, 2024 |
Estimated Total Program Funding: | $2,100,000 |
Award Ceiling: | $350,000 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Special district governments Small businesses For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Native American tribal governments (Federally recognized) City or township governments Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities |
Additional Information on Eligibility: | Please see Section III. Eligibility Information |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health.The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth). |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:ncipc_erpo@cdc.gov |
Related Documents
Folder 347316 Full Announcement-Full Announcement -> Foa_Content_of_RFA-CE-24-012.pdf
Folder 347316 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_RFA-CE-24-012 Modification 1.pdf
Folder 347316 Revised Full Announcement-Revised Full Announcement -> Foa_Content_of_RFA-CE-24-012 Modification 2.pdf
Folder 347316 Other Supporting Documents-Other Supporting Documents -> RFA-CE-24-012 Questions and Answers_final.pdf
Packages
Agency Contact Information: | Joyce Dieterly, MPH ncipc_erpo@cdc.gov Email: ncipc_erpo@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.136 | RFA-CE-24-012 | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) | PKG00283024 | Sep 29, 2023 | Dec 01, 2023 | View |
Package 1
Mandatory forms
347316 RR_SF424_5_0-5.0.pdf
347316 PHS398_CoverPageSupplement_5_0-5.0.pdf
347316 PHS398_ResearchPlan_5_0-5.0.pdf
347316 RR_Budget_3_0-3.0.pdf
347316 RR_OtherProjectInfo_1_4-1.4.pdf
347316 PerformanceSite_4_0-4.0.pdf
347316 RR_KeyPersonExpanded_4_0-4.0.pdf
347316 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347316 RR_SubawardBudget30_3_0-3.0.pdf